Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vazquez, Ignacio
ICON9, NCT03278717: Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients	Recruiting	3	330	Europe, Canada, RoW	Olaparib, Cediranib	University College, London	Ovarian Cancer	12/23	12/23
MONITOR-UK, NCT04295577: Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR	Recruiting	N/A	350	Europe	Niraparib	Royal Marsden NHS Foundation Trust	Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer	02/24	02/24